Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 23Breast Neoplasms 14Neoplasms 7Carcinoma, Ovarian Epithelial 6Testicular Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Fatigue 5Burkitt Lymphoma 5Blast Crisis 5Urinary Bladder Neoplasms 4Primary Myelofibrosis 4Neuroblastoma 4Multiple Myeloma 4Leukemia, Myeloid, Acute 4Leukemia, Hairy Cell 4Depression 4Pdgfra-Associated Chronic Eosinophilic Leukemia 3Myeloproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Lung Neoplasms 3

Interventions

padeliporfin 5Lycopene 3pembrolizumab 2darolutamide 2Vitamin E 2Tea 2Selenium 2Cholecalciferol 2relatlimab 1palladium-bacteriopheophorbide 1olaparib 1gedatolisib 1enfortumab vedotin 1Therapeutics 1Sugars 1Radiation Dose Hypofractionation 1Pluvicto 1Nivolumab 1Mitomycin 1Intraoperative Neurophysiological Monitoring 1Gemcitabine 1Fluorouracil 1Cisplatin 1CP protocol 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Male Urogenital Diseases × Therapeutics × Genitourinary × Clear all
NCT00975429 2015-04-28

Study Using WST11 in Patients With Localized Prostate Cancer

Steba Biotech S.A.

Phase 2 Completed
86 enrolled
Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡